相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of ITPA gene polymorphisms with adverse effects of AZA/6-MP administration: a systematic review and meta-analysis
Evaggelia Barba et al.
PHARMACOGENOMICS JOURNAL (2022)
Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy
Seth E. Karol et al.
HAEMATOLOGICA (2022)
Childhood cancer: Estimating regional and global incidence
W. T. Johnston et al.
CANCER EPIDEMIOLOGY (2021)
Effects of TPMT, NUDT15, and ITPA Genetic Variants on 6-Mercaptopurine Toxicity for Pediatric Patients With Acute Lymphoblastic Leukemia in Yunnan of China
Xiaoyan Mao et al.
FRONTIERS IN PEDIATRICS (2021)
Association Between Genetic Polymorphisms of Metabolic Enzymes and Azathioprine-Induced Myelosuppression in 1,419 Chinese Patients: A Retrospective Study
Zhao-Yang Chen et al.
FRONTIERS IN PHARMACOLOGY (2021)
TPMT*3C as a Predictor of 6-Mercaptopurine-Induced Myelotoxicity in Thai Children with Acute Lymphoblastic Leukemia
Thawinee Jantararoungtong et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Cancer in Africa: Is It a Genetic or Environmental Health Problem?
Abeer A. Bahnassy et al.
FRONTIERS IN ONCOLOGY (2020)
ESR1 rs2234693 Polymorphism Is Associated with Muscle Injury and Muscle Stiffness
Hiroshi Kumagai et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2019)
Impact of NUDT15 genetics on severe thiopurine-related hematotoxicity in patients with European ancestry
Elke Schaeffeler et al.
GENETICS IN MEDICINE (2019)
Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease
Gareth J. Walker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Pathway genes and metabolites in thiopurine therapy in Korean children with acute lymphoblastic leukaemia
Rihwa Choi et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update
Mary Relling et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Optimal predictor for 6-mercaptopurine intolerance in Chinese children with acute lymphoblastic leukemia: NUDT15, TPMT, or ITPA genetic variants?
Hong Zhou et al.
BMC CANCER (2018)
Thiopurine-induced toxicity is associated with dysfunction variant of the human molybdenum cofactor sulfurase gene (xanthinuria type II)
Blanka Stiburkova et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
Estimates of Cancer Incidence in Ethiopia in 2015 Using Population-Based Registry Data
Solomon Tessema Memirie et al.
JOURNAL OF GLOBAL ONCOLOGY (2018)
VARIANTS IN TPMT, ITPA, ABCC4 AND ABCB1 GENES AS PREDICTORS OF 6-MERCAPTOPURINE INDUCED TOXICITY IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
Goran Milosevic et al.
JOURNAL OF MEDICAL BIOCHEMISTRY (2018)
Genotypes Affecting the Pharmacokinetics of Anticancer Drugs
Daphne Bertholee et al.
CLINICAL PHARMACOKINETICS (2017)
Optimizing Combination Therapy for Acute Lymphoblastic Leukemia Using a Phenotypic Personalized Medicine Digital Health Platform: Retrospective Optimization Individualizes Patient Regimens to Maximize Efficacy and Safety
Dong-Keun Lee et al.
SLAS TECHNOLOGY (2017)
Risk factors for thiopurine-induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype
M. M. T. J. Broekman et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
NUDT15 c.415C>T increases risk of 6-mercaptopurine induced myelosuppression during maintenance therapy in children with acute lymphoblastic leukemia
Kanhatai Chiengthong et al.
HAEMATOLOGICA (2016)
NUDT15 c.415C>T increases risk of 6-mercaptopurine induced myelosuppression during maintenance therapy in children with acute lymphoblastic leukemia
Kanhatai Chiengthong et al.
HAEMATOLOGICA (2016)
NUDT15 Hydrolyzes 6-Thio-DeoxyGTP to Mediate the Anticancer Efficacy of 6-Thioguanine
Nicholas C. K. Valerie et al.
CANCER RESEARCH (2016)
Replication of a genetic variant in ACYP2 associated with cisplatin-induced hearing loss in patients with osteosarcoma
Hanneke I. Vos et al.
PHARMACOGENETICS AND GENOMICS (2016)
Polymorphisms of the thiopurine S-methyltransferase gene among the Libyan population
Hamza Ben Zeglam et al.
LIBYAN JOURNAL OF MEDICINE (2015)
Genetic variants in 6-mercaptopurine pathway as potential factors of hematological toxicity in acute lymphoblastic leukemia patients
Mohammad Salem Hareedy et al.
PHARMACOGENOMICS (2015)
Association of ITPA Genotype with Event-Free Survival and Relapse Rates in Children with Acute Lymphoblastic Leukemia Undergoing Maintenance Therapy
Alenka Smid et al.
PLOS ONE (2014)
In Vitro Oxidative Metabolism of 6-Mercaptopurine in Human Liver: Insights into the Role of the Molybdoflavoenzymes Aldehyde Oxidase, Xanthine Oxidase, and Xanthine Dehydrogenase
Kanika V. Choughule et al.
DRUG METABOLISM AND DISPOSITION (2014)
Inosine Triphosphate Pyrophosphohydrolase (ITPA) polymorphic sequence variants in adult hematological malignancy patients and possible association with mitochondrial DNA defects
Mazin A. Zamzami et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
Polymorphism of Genes Involved in Purine Metabolism (XDH, AOX1, MOCOS) in Kidney Transplant Recipients Receiving Azathioprine
Mateusz Kurzawski et al.
THERAPEUTIC DRUG MONITORING (2012)
Thiopurine metabolism monitoring: implications in inflammatory bowel diseases
Olivier Dewit et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
Genetic Polymorphism of Inosine Triphosphate Pyrophosphatase Is a Determinant of Mercaptopurine Metabolism and Toxicity During Treatment for Acute Lymphoblastic Leukemia
G. Stocco et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Treatment Strategies and Regimens of Graduated Intensity for Childhood Acute Lymphoblastic Leukemia in Low-Income Countries: A Proposal
Stephen P. Hunger et al.
PEDIATRIC BLOOD & CANCER (2009)
Analysis of ITPA phenotype-genotype correlation in the Bulgarian population revealed a novel gene variant in Exon 6
Srebrena Atanasova et al.
THERAPEUTIC DRUG MONITORING (2007)
Thiopurine S-methyltransferase pharmacogenetics:: insights, challenges and future directions
L Wang et al.
ONCOGENE (2006)
Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency in the Japanese population
T Maeda et al.
MOLECULAR GENETICS AND METABOLISM (2005)
Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase)
AM Marinaki et al.
PHARMACOGENETICS (2004)
分享论文
